 bronchial hyperresponsiveness salbutamol year subsensitization long-term administration inhaled beta bronchial hyperresponsiveness BHR consequence subsensitization inhaled beta hypothesis groups patients asthma chronic obstructive pulmonary disease experimental group patients micrograms salbutamol times year micrograms ipratropium times months control group patients opposite treatment regimen BHR response doses salbutamol number beta antagonist affinity receptors lymphocytes start study intervals years BHR year salbutamol value start study ipratropium bromide months change bronchodilating responses cumulative doses salbutamol change number affinity beta lymphocytes long-term use salbutamol small significant increase BHR increase BHR subsensitization beta